Eustrongylidosis
A parasitic disease affecting fish and birds
Eustrongylidosis is a parasitic disease caused by nematodes of the genus Eustrongylides. This disease primarily affects fish and piscivorous birds, leading to significant ecological and economic impacts.
Life Cycle[edit]
The life cycle of Eustrongylides involves multiple hosts. The adult nematodes reside in the intestines of piscivorous birds, where they lay eggs that are excreted with the bird's feces. These eggs hatch in aquatic environments, releasing larvae that are ingested by aquatic invertebrates, such as oligochaetes.

Fish, such as gobies, become infected when they consume these invertebrates. The larvae migrate to the fish's tissues, where they develop into third-stage larvae. Piscivorous birds become infected when they eat infected fish, completing the life cycle.
Symptoms in Fish[edit]
Infected fish may exhibit a range of symptoms, including:
- Abdominal swelling
- Hemorrhaging
- Tissue necrosis
- Behavioral changes such as erratic swimming
These symptoms can lead to increased mortality rates in fish populations, affecting both wild and farmed fish.
Impact on Birds[edit]
In piscivorous birds, Eustrongylides can cause:
- Gastrointestinal distress
- Weight loss
- Reduced reproductive success
Severe infections may lead to death, impacting bird populations and the ecosystems they inhabit.
Diagnosis and Treatment[edit]
Diagnosis of Eustrongylidosis in fish and birds is typically achieved through necropsy and identification of the nematodes in tissues. Treatment options are limited, and control measures focus on managing intermediate host populations and preventing the spread of infection.
Prevention and Control[edit]
Preventive measures include:
- Monitoring and managing water quality
- Controlling populations of intermediate hosts
- Implementing biosecurity measures in aquaculture settings
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian